203 related articles for article (PubMed ID: 32514992)
21. [Nephrological aspects of complement-mediated thrombotic microangiopathy].
Smirnov AV; Karunnaya AV; Dobronravov VA
Ter Arkh; 2017; 89(6):34-40. PubMed ID: 28745687
[TBL] [Abstract][Full Text] [Related]
22. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus.
Bermea RS; Sharma N; Cohen K; Liarski VM
J Clin Rheumatol; 2016 Sep; 22(6):320-3. PubMed ID: 27556240
[TBL] [Abstract][Full Text] [Related]
23. At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature.
Åkesson A; Zetterberg E; Klintman J
Ther Apher Dial; 2017 Aug; 21(4):304-319. PubMed ID: 28508588
[TBL] [Abstract][Full Text] [Related]
24. Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
Fujita Y; Terashita M; Yazawa M; Yamasaki Y; Imamura T; Kibayashi J; Sawai T; Hidaka Y; Ohtani K; Inoue N; Shibagaki Y
Intern Med; 2020; 59(1):93-99. PubMed ID: 31902910
[TBL] [Abstract][Full Text] [Related]
25. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
[TBL] [Abstract][Full Text] [Related]
26. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
[TBL] [Abstract][Full Text] [Related]
27. Hemolytic Uremic Syndrome: A Case Report.
Gaire S; Shrestha M; Bhattarai CD; Dhungana S; Gyawali S; Bajgain A
JNMA J Nepal Med Assoc; 2023 May; 61(261):472-474. PubMed ID: 37203902
[TBL] [Abstract][Full Text] [Related]
28. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
[TBL] [Abstract][Full Text] [Related]
29. The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics.
Java A; Kim AHJ
J Rheumatol; 2023 Jun; 50(6):730-740. PubMed ID: 36642429
[TBL] [Abstract][Full Text] [Related]
30. Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient.
Singh G; Wakhare P; Sajgure AD; Bale C; Shinde N
Cureus; 2024 May; 16(5):e60872. PubMed ID: 38910744
[TBL] [Abstract][Full Text] [Related]
31. Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series.
de Nattes T; Moreau-Grangé L; Vezzosi D; Hadoux J; Hie M; Guerrot D; Grangé S
BMC Nephrol; 2020 Jan; 21(1):35. PubMed ID: 32000700
[TBL] [Abstract][Full Text] [Related]
32. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
Timmermans SAMEG; Abdul-Hamid MA; Vanderlocht J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
Kidney Int; 2017 Jun; 91(6):1420-1425. PubMed ID: 28187980
[TBL] [Abstract][Full Text] [Related]
33. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
[TBL] [Abstract][Full Text] [Related]
34. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
[TBL] [Abstract][Full Text] [Related]
35. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
Sridharan M; Go RS; Willrich MAV
J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
[TBL] [Abstract][Full Text] [Related]
36. Postoperative Atypical Hemolytic Uremic Syndrome in a 67-Year-Old Woman Associated with Hemolytic Anemia, Thrombocytopenia, and Acute Renal Failure.
Chowdhury A; Griffith MP; Busse E; Pasha AK
Am J Case Rep; 2020 Dec; 21():e925662. PubMed ID: 33335086
[TBL] [Abstract][Full Text] [Related]
37. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
[TBL] [Abstract][Full Text] [Related]
38. Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.
Marini SC; Gomes M; Guilherme R; Carda JP; Pinto CS; Fidalgo T; Ribeiro ML
Blood Coagul Fibrinolysis; 2019 Mar; 30(2):68-70. PubMed ID: 30676336
[TBL] [Abstract][Full Text] [Related]
39. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
[TBL] [Abstract][Full Text] [Related]
40. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
Page EE; Little DJ; Vesely SK; George JN
Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
